journal article·2012-01-13Open access

Monodisperse 130 kDa and 260 kDa Recombinant Human Hemoglobin Polymers as Scaffolds for Protein Engineering of Hemoglobin-Based Oxygen Carriers

David A. Marquardt, Michael P. Doyle, Jeffrey S. Davidson, Janet K. Epp, Jacqueline F. Aitken, Douglas D. Lemon, Spencer J. Anthony-Cahill

Abstract

A recombinant 130 kDa dihemoglobin which is made up of a single-chain tetra-α globin and four β globins has been expressed as a soluble protein in E. coli. The sequence of the single chain tetra-α is: αI-Gly-αII-(SerGlyGly)5Ser-αIII-Gly-αIV. This dihemoglobin has been purified and characterized in vitro by size exclusion chromatography, electrospray mass spectroscopy, equilibrium oxygen binding, and analytical ultracentrifugation. The observed values of P50 and nmax for the dihemoglobin are slightly lower than those observed for the recombinant hemoglobin rHb1.1 (a “monohemoglobin” comprised of two β globins and an αI-Gly-αII diα-globin chain). Titration of the deoxy form of dihemoglobin with CO shows that all eight heme centers bind ligand. In vivo, dihemoglobin showed increased circulating halflife and a reduced pressor response in conscious rats when compared to rHb1.1. These observations suggest that dihemoglobin is an oxygen carrying molecule with desirable in vivo properties and provides a platform for an isooncotic hemoglobin solution derived solely from a recombinant source. A 260 kDa tetrahemoglobin has also been produced by chemical crosslinking of a dihemoglobin that contains a Lys16Cys mutation in the C-terminal α-globin subunit. Tetrahemoglobin also shows reduced vasoactivity in conscious rats that is comparable to that observed for dihemoglobin.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Neonatal Health and Biochemistry · Heme Oxygenase-1 and Carbon Monoxide

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research and Development, Baxter Hemoglobin Therapeutics, 2545 Central Avenue, Boulder, CO 80301, USA

Somatogen Inc., 2545 Central Avenue, Boulder, CO 80301, USA

References (34)

Show source-provided references
1. Winslow, R.M. (2006). Blood Substitutes, Academic Press.
2. Basic science focus on blood substitutes: A summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 200610.1111/j.1537-2995.2007.01604.x ↗
3. Hemoglobin-based oxygen carriers: Current status and future directions10.1097/ALN.0b013e3181ba3c2c ↗
4. Hemoglobin-based oxygen carriers: Research and reality towards an alternative to blood transfusions
5. Hemoglobin-based oxygen carriers for reversing hypotension and shock10.1097/ALN.0b013e318215e20b ↗
6. Bunn, H.F., and Forget, B.F. (1986). Hemoglobin: Molecular, Genetic and Clinical Aspects, W. B. Saunders.
7. The allosteric properties of hemoglobin: Insights from natural and site directed mutants10.2174/138920306775474121 ↗
8. A human recombinant haemoglobin designed for use as a blood substitute10.1038/356258a0 ↗
9. The development and preclinical testing of a second-generation recombinant hemoglobin solution, rHb2.0 for injection10.1159/000078251 ↗
10. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin10.1038/nbt0798-672 ↗
11. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity10.1152/japplphysiol.00175.2002 ↗
12. Glutaraldehyde modification of recombinant hemoglobin alters its hemodynamic properties10.1074/jbc.274.4.2583 ↗
13. Recombinant hemoglobins as artificial oxygen carriers10.1080/10731190600974467 ↗
14. Vascular response to infusions of a nonextravasating hemoglobin polymer10.1152/japplphysiol.00191.2002 ↗
15. Genetically engineered polymers of human CuZn superoxide dismutase. Biochemistry and serum half-lives10.1016/S0021-9258(18)83727-9 ↗
16. A range of catalytic efficiencies with avian retroviral protease subunits genetically linked to form single polypeptide chains10.1016/S0021-9258(19)67741-0 ↗
17. Covalent attachment of Arc repressor subunits by a peptide linker enhances affinity for operator DNA10.1021/bi9521194 ↗
18. Single-chain antigen binding proteins10.1126/science.3140379 ↗
19. Miniantibodies: Use of amphipathic helixes to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli10.1021/bi00121a001 ↗
20. Diabodies: Small bivalent and bispecific antibody fragments10.1073/pnas.90.14.6444 ↗
21. HLH forced dimers: Tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id10.1016/0092-8674(93)90725-6 ↗
22. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion10.1016/0022-2836(90)90085-Z ↗
23. Turnover of recombinant human hemoglobin in Escherichia coli occurs rapidly for insoluble and slowly for soluble globin10.1006/abbi.1997.0410 ↗
24. Genetically crosslinked hemoglobin: A structural study10.1107/S0907444900006557 ↗
25. Co-expression of α- and circularly permuted β-globins yields a hemoglobin with normal R state but modified T state properties10.1021/bi900216p ↗
26. Low-pressure solubility of gases in liquid water10.1021/cr60306a003 ↗
27. A correlation of the visible and Soret spectra of dioxygen- and carbon monoxide-heme complexes and five-coordinate heme complexes with the spectra of oxy-, carboxy- and deoxyhemoglobins10.1021/bi00589a026 ↗
28. The efficacy of polymerized pyridoxylated hemoglobin solution as an O2 carrier10.1097/00000658-199004000-00003 ↗
29. Ralston, G. (1993). Introduction to Analytical Ultracentrifugation, Beckman Instruments, Inc.
30. Hemoglobin Rouen (α-140 (HC2) Tyr→His): Alteration of the α-chain C-terminal region and moderate increase in oxygen affinity10.1016/0925-4439(92)90026-J ↗
31. Site-directed mutagenesis in hemoglobin: Functional and structural role of the penultimate tyrosine in the α subunit10.1021/bi00175a025 ↗
32. Cell-free oxygen carriers: Scientific foundations, clinical development, and new directions10.1016/j.bbapap.2008.04.032 ↗
33. Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction10.1152/japplphysiol.00622.2009 ↗
34. Therapeutic applications of polymeric artificial cells10.1038/nrd1659 ↗